NextGen Acquisition Corp II M&A Partner Virgin Orbit CEO Dan Hart Says About 18 Space Launches Lined Up Until 2023

Avicanna Inc., (TSX: AVCN) (OTCQX: AVCNF) a biopharmaceutical company focused on cannabinoid-based medicines, has filed a provisional patent application that aims to patent the use of a novel cannabinoid formulation for reducing or eliminating seizures and sudden death in epilepsy.